NuVasive, Inc.
Index- P/E- EPS (ttm)-0.79 Insider Own0.20% Shs Outstand51.83M Perf Week5.34%
Market Cap2.65B Forward P/E20.31 EPS next Y2.62 Insider Trans-9.12% Shs Float51.37M Perf Month-11.09%
Income-37.40M PEG- EPS next Q0.56 Inst Own- Short Float8.21% Perf Quarter4.00%
Sales1.16B P/S2.28 EPS this Y-71.90% Inst Trans-1.58% Short Ratio7.35 Perf Half Y-8.12%
Book/sh15.67 P/B3.39 EPS next Y12.91% ROA-1.70% Target Price64.77 Perf Year-24.63%
Cash/sh- P/C- EPS next 5Y11.30% ROE-4.60% 52W Range45.45 - 71.94 Perf YTD1.18%
Dividend- P/FCF70.01 EPS past 5Y-30.60% ROI-1.10% 52W High-26.19% Beta1.10
Dividend %- Quick Ratio1.90 Sales past 5Y3.40% Gross Margin71.60% 52W Low16.83% ATR2.79
Employees2900 Current Ratio3.20 Sales Q/Q7.20% Oper. Margin-1.10% RSI (14)48.37 Volatility3.71% 5.43%
OptionableYes Debt/Eq0.00 EPS Q/Q309.90% Profit Margin-3.20% Rel Volume0.57 Prev Close54.40
ShortableYes LT Debt/Eq1.09 EarningsMay 04 AMC Payout- Avg Volume574.07K Price53.10
Recom2.50 SMA20-1.08% SMA50-2.01% SMA200-3.75% Volume329,835 Change-2.39%
Apr-13-22Resumed Truist Buy $60 → $65
Mar-28-22Initiated Wells Fargo Overweight $58
Dec-10-21Initiated RBC Capital Mkts Outperform $60
Nov-10-21Reiterated UBS Sell $59 → $54
Nov-10-21Reiterated Truist Buy $80 → $75
Nov-10-21Reiterated Needham Buy $73 → $64
Nov-10-21Reiterated Credit Suisse Outperform $84 → $83
Nov-10-21Reiterated Citigroup Buy $82 → $70
Nov-10-21Reiterated Canaccord Genuity Hold $63 → $60
Dec-16-20Upgrade Citigroup Neutral → Buy $60
Dec-15-20Downgrade Wells Fargo Equal Weight → Underweight $48
Oct-30-20Downgrade Robert W. Baird Outperform → Neutral $76 → $56
Oct-30-20Downgrade Canaccord Genuity Buy → Hold $52
Oct-30-20Downgrade BTIG Research Buy → Neutral
Oct-20-20Initiated Stifel Buy $64
Jun-25-20Initiated Northland Capital Market Perform $65
Jun-23-20Upgrade Needham Hold → Buy
Apr-08-20Upgrade Robert W. Baird Neutral → Outperform $66
Mar-05-20Initiated Citigroup Neutral $68
Jan-08-20Initiated SunTrust Buy $93
May-10-22 06:48AM  
May-05-22 09:41AM  
May-04-22 06:35PM  
May-03-22 10:34AM  
Apr-27-22 03:03PM  
Apr-26-22 07:00AM  
Apr-21-22 07:00AM  
Apr-20-22 04:10PM  
Apr-14-22 11:57AM  
Mar-31-22 09:13AM  
Mar-29-22 08:55AM  
Mar-25-22 11:30AM  
Feb-28-22 09:37AM  
Feb-24-22 10:05AM  
Feb-23-22 06:55PM  
Feb-22-22 07:00AM  
Feb-08-22 02:38PM  
Jan-31-22 04:10PM  
Jan-19-22 09:38PM  
Jan-10-22 10:08AM  
Jan-05-22 07:00AM  
Dec-28-21 07:00AM  
Dec-06-21 08:07AM  
Nov-18-21 07:00AM  
Nov-16-21 10:37AM  
Nov-15-21 01:11PM  
Nov-10-21 09:50AM  
Nov-09-21 05:35PM  
Nov-02-21 03:02PM  
Nov-01-21 07:00AM  
Oct-28-21 07:00AM  
Oct-27-21 07:00AM  
Oct-26-21 10:41AM  
Oct-25-21 07:00AM  
Oct-21-21 10:12AM  
Oct-18-21 10:03AM  
Oct-14-21 07:00AM  
Sep-30-21 07:00AM  
Sep-27-21 08:27AM  
Sep-23-21 07:00AM  
Sep-22-21 07:00AM  
Sep-09-21 07:00AM  
Sep-06-21 12:12PM  
Sep-01-21 04:10PM  
Aug-30-21 07:00AM  
Aug-27-21 11:31AM  
Aug-13-21 06:12AM  
Aug-09-21 04:10PM  
Jul-30-21 07:00AM  
Jul-29-21 09:57AM  
Jul-28-21 11:32PM  
Jul-23-21 07:06AM  
Jul-22-21 07:00AM  
Jul-21-21 10:23PM  
Jul-14-21 04:10PM  
Jul-13-21 10:06AM  
Jul-09-21 09:51AM  
Jun-30-21 07:00AM  
Jun-17-21 08:01AM  
Jun-04-21 11:31AM  
May-19-21 04:03PM  
May-12-21 02:57AM  
May-10-21 04:03PM  
May-07-21 08:21AM  
May-06-21 08:55AM  
May-05-21 06:15PM  
May-04-21 07:50AM  
May-03-21 04:03PM  
Apr-28-21 12:33PM  
Apr-20-21 10:24AM  
Apr-19-21 04:03PM  
Apr-07-21 01:28PM  
Apr-06-21 04:03PM  
Mar-29-21 06:31AM  
Mar-27-21 11:31AM  
Mar-25-21 04:03PM  
Mar-19-21 01:18PM  
Mar-17-21 08:23AM  
Mar-16-21 10:54AM  
Mar-01-21 07:48AM  
Feb-26-21 12:01PM  
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rosenberg Donald JDirectorMay 11Option Exercise0.0013,326022,519May 13 06:06 PM
Barry James ChristopherChief Executive OfficerApr 13Sale58.005,000290,00050,218Apr 15 05:49 PM
Barry James ChristopherChief Executive OfficerMar 28Sale55.005,000275,00055,218Mar 30 05:50 PM
Wolf Dale A.SVP, Global OperationsMar 01Option Exercise0.004,01507,038Mar 03 05:54 PM
SISITSKY NATHANIELSVP & General CounselMar 01Option Exercise0.008,029020,918Mar 03 05:51 PM
Calafiore MassimoEVP, Chief Commercial OfficerMar 01Option Exercise0.008,699010,295Mar 03 05:47 PM
Barry James ChristopherChief Executive OfficerMar 01Option Exercise0.0053,523081,010Mar 03 05:46 PM
Barry James ChristopherChief Executive OfficerNov 05Option Exercise0.0029,904039,830Nov 09 05:50 PM
Wolf Dale A.SVP, Global OperationsSep 01Option Exercise0.004,25604,256Sep 03 05:50 PM
Calafiore MassimoEVP, Chief Commercial OfficerSep 01Option Exercise0.001,41902,086Sep 03 05:47 PM
Barry James ChristopherChief Executive OfficerJun 25Sale70.005,000350,0009,926Jun 29 05:45 PM
Barry James ChristopherChief Executive OfficerJun 21Sale68.005,000340,00014,926Jun 23 05:53 PM
Norwalk Leslie VDirectorJun 01Option Exercise0.001,54801,548Jun 03 05:56 PM